Summary
Age is the major demographic risk factor for the development of Alzheimer’s disease (AD) and the ageing of our society has contributed to the growing importance of AD. The problem of AD has been tackled from numerous clinical and scientific angles. The traditional clinico-pathological disease concept, which relies on the manifestation of a dementia syndrome and the elimination of other relevant systemic and brain diseases for a diagnosis of AD, accommodates a number of genetically and clinically heterogenous conditions, but cannot promote our understanding of the preclinical pathogenetic processes and their interaction. If new molecular biological discoveries cannot be integrated with this traditional clinico-pathological model, it may have outlived its usefulness.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alzheimer A (1911) Über eigenartige Krankheitsfälle des späteren Alters. Z Ges Neurol Psychiat 4: 356–385
Baumgart P, Helgenberger F, Weyerer S, Pfeifer-Kurda M, Försti H (1995) The course of cognition and depression in the elderly patients with affective disturbances and mild cognitive impairment. Int J Geriat Psychiat 10: 419–421
Berg L (1984) Clinical dementia rating. Br J Psychiatry 145: 339
Beyreuther K (1997) Molekularbiologie der Alzheimer Demenz. Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart
Bickel H (1997) Epidemiologie psychischer Erkrankungen im Alter. Lehrbuch der Gerontopsychiatrie. Enke, Stuttgart
Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen L, Reynolds GP (1987) Age and histopathological heterogeneity in Alzheimer’s disease: evidence for subtypes. Arch Gen Psychiatry 44: 412–417
Burns A, Jacoby R, Levy R (1991) Progression of cognitive impairment in Alzheimer’s disease. J Am Geriatr Soc 39: 39–45
Chui HC, Teng EL, Henderson VW, Moy AC (1985) Clinical subtypes of dementia of the Alzheimer type. Neurology 35: 1544–1550
van Duijn CM (1996) Epidemiology of the dementia: recent developments and new approaches. J Neurol Neurosurg Psychiatry 60: 478–488
Försti H, Hentschel F, Sattel H, Geiger-Kabisch C, Besthorn C, Czech C, Mönning U, Beyreuther K (1995) Age-associated memory impairment and early Alzheimer’s disease — only time will tel the difference. Drug Res 45: 394–397
Förstl H, Zerfass R, Geiger-Kabisch C, Sattel H, Besthorn C, Hentschel F (1995) Brain atrophy in normal ageing and Alzheimer’s disease — volumetric discrimination and clinical correlations. Br J Psychiatry 167: 739–746
Förstl H, Sattel H, Besthorn C, Daniel S, Geiger-Kabisch C, Hentschel F, Sarochan M, Zerfass R (1996) Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and Alzheimer’s disease. Br J Psychiatry 168: 280–286
Girling DM, Berrios GE (1991) Extrapyramidal signs, primitive reflexes and frontal lobe functional in senile dementia of the Alzheimer type. Br J Psychiatry 157: 888–893
Haupt M, Kurz A, Romero B, et al (1992) Symptomprogression bei Alzheimerscher Krankheit: gibt es einen Zusammenhang mit dem Manifestationsalter oder der familiären Belastung. Z Gerontopsychol -psychiat 4: 91–98
Lopez OL, Becker JT, Brenner RP, et al (1991) Alzheimer’s disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 41: 906–912
Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 35: 53–61
McDonald C (1969) Clinical heterogeneity in senile dementia. Br J Psychiatry 115: 267–271
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheier’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944
Mielke R, Herholz K, Grond M, et al (1994) Clinical deterioration in probable Alzheimer’s disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36–41
Miller TP, Tinklenberg JR, Brooks JO, Fenn HH, Yesavage JA (1991) Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer’s disease. J Geriat Psychiat Neurol 6: 235–238
Morris JC, Rubin EG (1993) Clinical diagnosis and course of Alzheimer’s disease. Psychiatr Clin North Am 14: 223–236
Mortimer JA, Ebbit B, Jun S, et al (1992) Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 42: 1689–1696
Ritchie K, Kildea D (1995) Is senile dementia “age-related” or “ageing-related”? — Evidence from meta-analyis of dementia prevalence in the oldest old. Lancet 346: 931–934
Teri L, Hughes JP, Larson EB (1990) Cognitive deterioration in Alzheimer’s disease: behavioural and health factors. J Gerontol 45: 58–63
WHO (1993) The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. WHO, Geneva
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Förstl, H. (1998). Alzheimer’s disease: the size of the problem, clinical manifestation and heterogeneity. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7508-8_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83112-0
Online ISBN: 978-3-7091-7508-8
eBook Packages: Springer Book Archive